Stock Analiz

Phreesia, Inc. PHR

Business Services · IPO 2019 · data as of November 13, 2026

$12.69Market cap $788M
Open the interactive analysis →

Phreesia, Inc. (PHR) is a consumer discretionary company listed in the US with a market value of about $788M. In the twelve months to July 31, 2026 it had revenue of $508M and net income of $10M, a net margin of 2.1%.

Its overall Stock Analiz score is 2.0 out of 5 (weak). The strongest part is future growth (4/5); the weakest is shareholder returns (0/5).

Key numbers: a P/E of 74.6, a price to free cash flow of 9.8, 5-year revenue growth of 26% a year, a 5-year average ROIC of -25%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 55% below the current price.

About Phreesia

Phreesia is listed in the US and classified in business services, IPO year 2019. Revenue went from $80M in 2018 to $481M in 2026, growth of about 25.2% a year. It was profitable in 1 of the last 9 years in our data. Its share count rose by 17% over three years (dilution for shareholders). It spends 25% of revenue on research and development.

Score: 2.0 / 5

Value1/5
Future growth4/5
Track record1/5
Financial health4/5
Shareholder returns0/5

Checks passed

  • P/FCF below 20
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving
  • Strong R&D investment or growth above 20%
  • 5-year revenue growth above 8% a year
  • More cash than debt, or low debt to equity
  • Positive free cash flow

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year average ROIC above 12%
  • Profitable 5 years in a row

Valuation

P/E (TTM)74.6
Forward P/E8.5
P/FCF9.8
P/S1.6
P/B2.1
EV/EBITDA15.7
PEG—
Dividend yield0.00%
FCF yield10.2%
Shareholder yield0.0%
Intrinsic value vs. price−55%

Growth and quality

Revenue growth (1 yr)14.5%
Revenue growth (5 yrs, per year)26.5%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-34.0%
ROIC (5-yr avg.)-25.3%
Profitable years (of last 10)1
Years paying a dividend—

Financials, last 9 years

Fiscal yearTTM202620252024202320222021202020192018
Revenue$508M$481M$420M$356M$281M$213M$149M$125M$100M$80M
Net income$10M$2M-$59M-$137M-$176M-$118M-$27M-$20M-$15M-$18M
Free cash flow$81M$68M$24M-$38M-$95M-$93M-$8M-$6M-$7M-$18M
EPS (diluted)$0.17$0.04$-1.02$-2.51$-3.36$-2.37$-0.69$-4.50$-24.53$-24.81
Net margin2.1%0.5%-13.9%-38.4%-62.7%-55.4%-18.4%-16.3%-15.1%-22.8%
ROIC—-1.2%-16.2%-40.9%-47.0%-21.3%-7.3%-11.2%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 15 analysts is $13.87, 9% above the current price; targets range from $10.00 to $19.00; the consensus rating is “Buy”; expected EPS is $1.26 for the fiscal year ending January 31, 2027.

Frequently asked questions

What is Phreesia’s P/E ratio?

About 74.6, based on the last twelve months of diluted earnings per share (forward P/E about 8.5).

Is Phreesia stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 55% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Phreesia pay a dividend?

Not currently.

Is Phreesia a good stock to buy?

We do not give buy or sell advice. Phreesia scores 2.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.